Skip to main content
. Author manuscript; available in PMC: 2007 Jan 9.
Published in final edited form as: Cancer Lett. 2006 Feb 14;245(1-2):163–170. doi: 10.1016/j.canlet.2006.01.003

Table 2.

Mutations and polymorphisms of the components of the TGF-β-Smad signaling pathway identified in the HNSCC cell lines.

Exonic mutations with presumed LOH
Gene Exon Codon Nucleotide change Amino acid change Presence of a wild-type allele Cell line
SMAD2 8 276 TCG→TTG Ser→Leu No SCC-15
SMAD4 5 245 CAG→TAG Glu→Stop No CAL27
Polymorphic changes in exonic coding regions
Gene Exon Codon Nucleotide change Presence of a wild-type allele (number of cell lines)
SMAD3 2 103 CTG(leu)→CTA(leu) No (2) Yes (3)
TGFBRI 1 18-26 del (GCG)3 Yes (2)
Polymorphic changes in intronic sequences
Gene Intron Nucleotide position Polymorphic change Presence of a wild-type allele (number of cell lines)
SMAD2 3 −39 to −56 (T18)del TT Yes (5)
3 −39 to −56 (T18)del T Yes (3)
SMAD3 2 +59 C→G No (3) Yes (2)
7 +159 T→C Yes (1)
SMAD4 6 +30 del T Yes (6)
6 +30 ins T Yes (1)
TGFBRI 7 +24 G→A No (2) Yes (1)
8 +86 del CTTTT No (2) Yes (1)
TGFBRII 2 +7 A→G No (2)
3 −4 T→A No (1)
6 −101 C→A Yes (1)

GenBank accession number: SMAD2: AF027964, U78727, U7872; SMAD3: AF025294, AF025298; SMAD4: U44378, AF045442; TGFBRI: AF054590, AF054596, AF054597; TGFBRII: AY675319.